Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK yes hybrid embryo R&D

This article was originally published in Clinica

Executive Summary

The UK's Human Fertilisation and Embryology Authority (HFEA) today announced the approval of two licences to conduct research using human-animal cytoplasmic hybrid embryos. Subject to a "series of detailed conditions in each case", Kings College London and Newcastle University will be able to perform the research for a period of one year. The applications were discussed at HFEA licence committee meetings on November 28 2007 and January 9 2008; minutes of the meetings are available from the HFEA (www.hfea.gov.uk).

You may also be interested in...



Mark Cuban ‘Very Involved’, Insists Generics Company CEO

Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.

Bharat Biotech To Make GSK’s Malaria Vaccine For WHO

GSK is transferring technology to make its malaria vaccine antigen to Bharat Biotech and by 2029 will also transfer rights to supply the vaccine to WHO-approved immunization programs. The deal is expected to improve access via lower cost of the vaccine for such programs

Irish Ad Code Covers OTC Devices And Herbals For First Time

Rules covering OTC medical devices, herbals and online activities have been added for the first time to the Irish Pharmaceutical Healthcare Association's Self-Care Advertising Code.

Topics

UsernamePublicRestriction

Register

OM005224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel